Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center

被引:0
|
作者
Felicia Y. Wang
Kevin C. McLaughlin
Michael J. Schontz
Jeremy R. DeGrado
Robert E. Dannemiller
机构
[1] Brigham and Women’s Hospital,Department of Pharmacy
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:175 / 181
页数:6
相关论文
共 50 条
  • [1] Safety of Intravenous Push Valproate Compared with Intravenous Piggyback at a Tertiary Academic Medical Center
    Wang, Felicia Y.
    McLaughlin, Kevin C.
    Schontz, Michael J.
    DeGrado, Jeremy R.
    Dannemiller, Robert E.
    [J]. CLINICAL DRUG INVESTIGATION, 2024, 44 (03) : 175 - 181
  • [2] SAFETY OF INTRAVENOUS PUSH VALPROATE COMPARED WITH PIGGYBACK AT A TERTIARY ACADEMIC MEDICAL CENTER
    Wang, Felicia
    McLaughlin, Kevin
    Schontz, Michael
    DeGrado, Jeremy
    Dannemiller, Robert
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [3] Safety of Intravenous Push Ertapenem Compared to Intravenous Piggyback at a Tertiary Academic Medical Center
    Corrado, Michael J.
    Riselli, Andrew
    McLaughlin, Kevin C.
    Szumita, Paul M.
    Anger, Kevin E.
    [J]. JOURNAL OF PHARMACY PRACTICE, 2023, 36 (02) : 281 - 285
  • [4] Safety of Intravenous Push Lacosamide Compared With Intravenous Piggyback at a Tertiary Academic Medical Center
    McLaughlin, Kevin
    Carabetta, Shannon
    Hunt, Nicholas
    Schuler, Brian R.
    Ting, Clara
    Tran, Lena K.
    Szumita, Paul M.
    Anger, Kevin E.
    [J]. ANNALS OF PHARMACOTHERAPY, 2021, 55 (02) : 181 - 186
  • [5] Safety of Intravenous Push Levetiracetam Compared to Intravenous Piggyback at a Tertiary Academic Medical Center: A Retrospective Analysis
    Afrah Alkazemi
    Kevin C. McLaughlin
    Michael G. Chan
    Michael J. Schontz
    Kevin E. Anger
    Paul M. Szumita
    [J]. Drug Safety, 2022, 45 : 19 - 26
  • [6] Safety of Intravenous Push Levetiracetam Compared to Intravenous Piggyback at a Tertiary Academic Medical Center: A Retrospective Analysis
    Alkazemi, Afrah
    McLaughlin, Kevin C.
    Chan, Michael G.
    Schontz, Michael J.
    Anger, Kevin E.
    Szumita, Paul M.
    [J]. DRUG SAFETY, 2022, 45 (01) : 19 - 26
  • [7] SAFETY OF INTRAVENOUS PUSH THIAMINE ADMINISTRATION AT A TERTIARY ACADEMIC MEDICAL CENTER
    McLaughlin, Kevin
    Joyal, Kayla
    Lee, Seungjoo
    Marquis, Kathleen
    Anger, Kevin
    Szumita, Paul
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [8] Safety of intravenous push thiamine administration at a tertiary academic medical center
    McLaughlin, Kevin
    Joyal, Kayla
    Lee, Seungjoo
    Corrado, Michael
    Marquis, Kathleen
    Anger, Kevin
    Szumita, Paul
    [J]. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2020, 60 (04) : 598 - 601
  • [9] SAFETY OF INTRAVENOUS PUSH LEVETIRACETAM ADMINISTRATION AT A TERTIARY ACADEMIC MEDICAL CENTER
    Alkazemi, Afrah
    Schontz, Michael
    Chan, Michael G.
    McLaughlin, Kevin
    Anger, Kevin
    Szumita, Paul
    [J]. CRITICAL CARE MEDICINE, 2021, 49 (01) : 9 - 9
  • [10] Evaluation of the safety of 500 mg intravenous push thiamine at a tertiary academic medical center
    Aldhaeefi, Mohammed
    McLaughlin, Kevin
    Goodberlet, Melanie
    Szumita, Paul
    [J]. SCIENCE PROGRESS, 2022, 105 (02)